Advisory: Alerts on Alligator Bioscience conducting rights issue withdrawn
07/09/2026 14:35
ADVISORY-Alerts on Alligator Bioscience conducting rights issue withdrawn Sept 7 (Reuters) - Please ignore a chain of alerts on Alligator Bioscience conducting rights issue of SEK 125.6 million. The chain repeats old news and has been withdrawn. Follow the link to see Reuters coverage of the company's capital increase.
STORY_NUMBER:FWN44W0ZY
STORY_DATE:07/09/2026
STORY_TIME:[12:17:15]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue